查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1933280

全球心室輔助裝置市場：市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的分析、未來預測（2026-2034）

Ventricular Assist Device Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 156 Pages | 商品交期: 請詢問到貨日

價格

心室輔助裝置 (VAD) 市場成長因素

由於全球心臟衰竭盛行率不斷上升以及機械循環支持系統的廣泛應用，全球心室輔助裝置 (VAD) 市場正經歷強勁增長。根據 Fortune Business Insights 的數據顯示，2025 年全球心室輔助裝置市場規模為 14.9 億美元。預計該市場將從 2026 年的 16.5 億美元成長到 2034 年的 42.5 億美元，在預測期（2026-2034 年）內，複合年增長率 (CAGR) 將達到 12.57%。北美地區憑藉先進的醫療基礎設施和創新心臟設備的高普及率，在2025年將佔全球心室輔助裝置（VAD）市場50.18%的市場佔有率。

市場概覽

心室輔助裝置（VAD）是一種植入式機械泵，旨在幫助重度心臟衰竭患者維持心臟功能和血液流動。這些裝置透過將血液泵送到全身來輔助心臟的左心室、右心室或雙心室。當無法立即進行心臟移植時，VAD被廣泛用作移植過渡治療（BTT）、根治性治療（DT）、移植過渡治療（BTC）和復健過渡治療（BRT）。

全球心臟衰竭負擔的加重是推動市場需求的主要因素。根據 "心臟衰竭雜誌" （2023 年）的數據，約有 670 萬 20 歲及以上的美國人患有心臟衰竭，預計到 2030 年這一數字將達到 850 萬。這將顯著增加對心室輔助裝置 (VAD) 的需求。

市場趨勢

快速的技術創新正在改變 VAD 市場。人工智慧 (AI) 和機器學習在心臟護理中的應用正在改善患者風險評估、手術計劃和術後監測。先進的 VAD，例如 HeartMate III 和 DuraHeart，具有體積更小、轉速更慢、解剖結構設計更優化以及感染風險更低等特點。

完全植入式系統是主要的創新趨勢。例如，獲得美國 FDA 批准的美敦力 HVAD 系統無需外部驅動電纜，從而降低了感染風險並提高了患者的活動能力。這些進步有望加速已開發市場和新興市場的普及。

市場成長驅動因素

心臟衰竭盛行率的上升是最重要的成長因素。西方國家約有1-2%的人口患有心臟衰竭，2020年全球受影響人數超過550萬人。人口老化進一步推高了疾病盛行率，使老年人面臨更高的心血管疾病風險。

另一個主要因素是心臟移植的漫長等待期。根據美國衛生資源和服務管理局（2022年）的數據，超過105,800名患者在器官移植等待名單上。由於捐贈心臟短缺，心室輔助裝置（VAD）越來越多地被用作長期根治性治療或移植過渡方案。

此外，市場參與者正集中精力進行研發和產品拓展。例如，2021年6月，雅培擴大了其HeartMate 3設備的供應，以滿足不斷增長的全球需求。

限制因子

儘管成長潛力強勁，但該市場面臨與心室輔助裝置（VAD）植入成本高昂相關的挑戰。在美國，左心室輔助裝置（LVAD）植入手術費用高達 17.5 萬美元至 20 萬美元，這限制了其在對成本敏感地區的普及。與設備相關的併發症，例如泵浦故障、電源問題和感染風險，進一步阻礙了設備的普及。

細分市場分析

依產品劃分，左心室輔助裝置 (LVAD) 細分市場將在 2026 年佔主導地位，市場佔有率達 87.10%，這主要得益於其高植入率和 FDA 的批准。

依血流類型劃分，連續流裝置將在 2026 年佔最大佔有率，達到 88.81%，這主要歸功於其耐用性、低維護成本和改善患者預後的優勢。

依應用領域劃分，預計根治性治療 (DT) 將在 2026 年佔領先地位，市場佔有率達 45.75%，而移植過渡治療 (BTT) 預計將呈現最高的增長率。

依最終用戶劃分，醫院和門診手術中心 (ASC) 將引領市場。預計到 2026 年，北美將佔 65.95% 的市場佔有率，這主要得益於其龐大的手術量。

區域洞察

預計到 2025 年，北美地區的收入將達到 7.5 億美元，憑藉其先進的心臟護理系統和有利的報銷政策，將繼續保持領先地位。歐洲將佔第二大市場佔有率，這主要得益於其強勁的研發投入。亞太地區預計將實現最高的複合年增長率，這主要得益於醫療基礎設施的持續改善和政府的支持，尤其是在中國、日本和印度。

目錄

第一章：引言

第二章：摘要整理

第三章：市場動態

  • 市場驅動因素
  • 市場限制因素
  • 市場機遇
  • 市場趨勢

第四章：關鍵考慮因素

  • 依地區劃分的心臟衰竭盛行率（2022/2025）
  • 依地區和國家劃分的心臟手術量（2022/2025）
  • 主要公司的新產品發布
  • 主要產業趨勢：併購、業務合作等
  • 新冠疫情的影響市場

第五章 全球心室輔助裝置市場分析：洞察與預測（2021-2034）

  • 市場分析、洞察與預測：依產品分類
    • 左心室輔助裝置
    • 右心室輔助裝置
    • 雙側心室輔助裝置
  • 市場分析、洞察與預測：依血流類型分類
    • 脈動血流
    • 連續血流
  • 市場分析、洞察與預測：依應用分類
    • 移植過渡治療（BTT）
    • 移植橋接治療（BTC）（移植橋接候選者）
    • 最終治療（DT）
    • 康復橋接治療（BTR）
  • 市場分析、洞察與預測：依最終用戶劃分
    • 醫院和門診手術中心 (ASC)
    • 專科診所，其他
  • 市場分析、洞察與預測：依地區劃分
    • 北美
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲

第六章：北美心室輔助裝置市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 美國
    • 加拿大

第七章：歐洲心室輔助裝置市場分析、洞察與預測（2021-2034）

  • 依國家/地區
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 斯堪的納維亞半島
    • 歐洲其他地區

第八章 亞太地區心室輔助裝置市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 中國
    • 日本
    • 印度
    • 澳大利亞
    • 東南亞
    • 亞太其他地區

第九章 拉丁美洲心室輔助裝置市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 巴西
    • 墨西哥
    • 其他地區拉丁美洲

第十章：中東和非洲心室輔助裝置市場分析、洞察與預測（2021-2034）

  • 依國家劃分
    • 海灣合作委員會 (GCC)
    • 南非
    • 中東和非洲其他地區

第11章 競爭分析

  • 全球市場佔有率分析(2025年)
  • 企業簡介
    • Berlin HeartOverview
    • ABIOMED
    • Abbott
    • Jarvik Heart, Inc.
Product Code: FBI106377

Growth Factors of ventricular assist device (VAD) Market

The global ventricular assist device (VAD) market is witnessing robust growth due to the rising prevalence of heart failure and increasing adoption of mechanical circulatory support systems worldwide. According to Fortune Business Insights, the global ventricular assist device market size was valued at USD 1.49 billion in 2025. The market is projected to grow from USD 1.65 billion in 2026 to USD 4.25 billion by 2034, registering a strong CAGR of 12.57% during the forecast period (2026-2034). North America dominated the global VAD market with a 50.18% market share in 2025, supported by advanced healthcare infrastructure and high adoption of innovative cardiac devices.

Market Overview

Ventricular assist devices are implantable mechanical pumps designed to support heart function and blood flow in patients suffering from severe heart failure. These devices assist the left, right, or both ventricles of the heart by pumping blood to the rest of the body. VADs are widely used as Bridge-to-Transplant (BTT), Destination Therapy (DT), Bridge-to-Candidacy (BTC), and Bridge-to-Recovery (BTR) solutions when heart transplantation is not immediately feasible.

The increasing global burden of heart failure is a major factor driving demand. As per the Journal of Cardiac Failure (2023), approximately 6.7 million Americans aged 20 and above were affected by heart failure, and this number is expected to reach 8.5 million by 2030, significantly boosting the need for ventricular assist devices.

Market Trends

Rapid technological advancements are transforming the VAD market. The integration of artificial intelligence (AI) and machine learning in cardiac care is improving patient risk assessment, surgical planning, and post-implantation monitoring. Advanced VADs such as HeartMate III and DuraHeart feature smaller sizes, lower rotational speeds, improved anatomic design, and reduced infection risks.

Fully implantable systems represent a key innovation trend. For instance, Medtronic's HVAD system, approved by the U.S. FDA, eliminates external driveline cables, reducing infection risks and improving patient mobility. Such advancements are expected to accelerate adoption across developed and emerging markets.

Market Growth Drivers

The rising prevalence of heart failure remains the most significant growth driver. Heart failure affects nearly 1-2% of the population in Western countries, and globally over 5.5 million individuals were affected in 2020. The growing geriatric population further increases disease prevalence, as elderly individuals are at higher risk of cardiovascular disorders.

Another major driver is the long waiting period for heart transplants. According to the Health Resources & Services Administration (2022), over 105,800 patients were on organ transplant waiting lists. Due to the shortage of donor hearts, VADs are increasingly used as long-term destination therapy and bridge-to-transplant solutions.

Additionally, market players are focusing on R&D initiatives and product expansion. For example, in June 2021, Abbott expanded the supply of its HeartMate 3 device to meet growing global demand.

Restraining Factors

Despite strong growth potential, the market faces challenges related to the high cost of VAD implantation. In the U.S., LVAD implantation procedures can cost between USD 175,000 and USD 200,000, limiting accessibility in cost-sensitive regions. Device-related complications such as pump failure, power supply issues, and infection risks further restrain adoption.

Segmentation Analysis

By product, the Left Ventricular Assist Device (LVAD) segment dominated the market, accounting for 87.10% share in 2026, driven by high implantation rates and FDA approvals.

By flow type, continuous flow devices held the largest share at 88.81% in 2026 due to durability, lower maintenance, and improved patient outcomes.

By application, Destination Therapy (DT) dominated with a 45.75% market share in 2026, while Bridge-to-Transplant is expected to grow at the fastest rate.

By end user, hospitals & ASCs led the market with 65.95% share in 2026, owing to a higher volume of surgical procedures.

Regional Insights

North America generated USD 0.75 billion in revenue in 2025 and continues to dominate due to advanced cardiac care systems and favorable reimbursement policies. Europe holds the second-largest share, driven by strong R&D investments. Asia Pacific is expected to witness the highest CAGR due to expanding healthcare infrastructure and supportive government initiatives, particularly in China, Japan, and India.

Conclusion

The global ventricular assist device market is poised for strong growth, expanding from USD 1.49 billion in 2025 to USD 4.25 billion by 2034. Rising heart failure prevalence, donor heart shortages, and rapid technological advancements in mechanical circulatory support systems are key factors driving market expansion. Although high implantation costs and device-related risks pose challenges, continuous innovation, expanding clinical applications, and improving healthcare infrastructure-especially in Asia Pacific-are expected to create significant long-term opportunities. Overall, the VAD market presents a highly promising outlook for manufacturers, healthcare providers, and investors throughout the forecast period.

Segmentation By Product

  • Left Ventricular Assist Device
  • Right Ventricular Assist Device
  • Bi-Ventricular Assist Device

By Type of Flow

  • Pulsatile Flow
  • Continuous Flow

By Application

  • Bridge to Transplant (BTT)
  • Bridge to Candidacy (BTC)
  • Destination Therapy (DT)
  • Bridge to Recovery (BTR)

By End-user

  • Hospitals & ASCs
  • Specialty Clinics & Others

By Geography

  • North America (By Product, By Type of Flow, By Application, and By Country)
    • U.S. (By Product)
    • Canada (By Product)
  • Europe (By Product, By Type of Flow, By Application, and By Country)
    • U.K. (By Product)
    • Germany (By Product)
    • France (By Product)
    • Italy (By Product)
    • Spain (By Product)
    • Rest of Europe (By Product)
  • Asia Pacific (By Product, By Type of Flow, By Application, and By Country)
    • China (By Product)
    • Japan (By Product)
    • India (By Product)
    • Australia (By Product)
    • Southeast Asia (By Product)
    • Rest of Asia Pacific (By Product)
  • Latin America (By Product, By Type of Flow, By Application, and By Country)
    • Brazil (By Product)
    • Mexico (By Product)
    • Rest of Latin America (By Product)
  • Middle East & Africa (By Product, By Type of Flow, By Application, and By Country)
    • GCC (By Product)
    • South Africa (By Product)
    • Rest of the Middle East & Africa (By Product)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Heart Failure, by Region, 2022/2025
  • 4.2. Number of Cardiac Surgeries, By Region/Country, 2022/2025
  • 4.3. New Product Launches, By Key Players
  • 4.4. Key Industry Developments (Mergers, Acquisitions, Partnerships; etc.)
  • 4.5. Impact of COVID-19 on the Market

5. Global Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Left Ventricular Assist Device
    • 5.1.2. Right Ventricular Assist Device
    • 5.1.3. Bi-Ventricular Assist Device
  • 5.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 5.2.1. Pulsatile Flow
    • 5.2.2. Continuous Flow
  • 5.3. Market Analysis, Insights and Forecast - By Application
    • 5.3.1. Bridge to Transplant (BTT)
    • 5.3.2. Bridge to Candidacy (BTC)
    • 5.3.3. Destination Therapy (DT)
    • 5.3.4. Bridge to Recovery (BTR)
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals & ASCs
    • 5.4.2. Specialty Clinics & Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Left Ventricular Assist Device
    • 6.1.2. Right Ventricular Assist Device
    • 6.1.3. Bi-Ventricular Assist Device
  • 6.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 6.2.1. Pulsatile Flow
    • 6.2.2. Continuous Flow
  • 6.3. Market Analysis, Insights and Forecast - By Application
    • 6.3.1. Bridge to Transplant (BTT)
    • 6.3.2. Bridge to Candidacy (BTC)
    • 6.3.3. Destination Therapy (DT)
    • 6.3.4. Bridge to Recovery (BTR)
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals & ASCs
    • 6.4.2. Specialty Clinics & Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
      • 6.5.1.1. By Product
    • 6.5.2. Canada
      • 6.5.2.1. By Product

7. Europe Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Left Ventricular Assist Device
    • 7.1.2. Right Ventricular Assist Device
    • 7.1.3. Bi-Ventricular Assist Device
  • 7.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 7.2.1. Pulsatile Flow
    • 7.2.2. Continuous Flow
  • 7.3. Market Analysis, Insights and Forecast - By Application
    • 7.3.1. Bridge to Transplant (BTT)
    • 7.3.2. Bridge to Candidacy (BTC)
    • 7.3.3. Destination Therapy (DT)
    • 7.3.4. Bridge to Recovery (BTR)
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals & ASCs
    • 7.4.2. Specialty Clinics & Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 7.5.1. Germany
      • 7.5.1.1. By Product
    • 7.5.2. France
      • 7.5.2.1. By Product
    • 7.5.3. U.K.
      • 7.5.3.1. By Product
    • 7.5.4. Italy
      • 7.5.4.1. By Product
    • 7.5.5. Spain
      • 7.5.5.1. By Product
    • 7.5.6. Scandinavia
      • 7.5.6.1. By Product
    • 7.5.7. Rest of Europe
      • 7.5.7.1. By Product

8. Asia Pacific Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Left Ventricular Assist Device
    • 8.1.2. Right Ventricular Assist Device
    • 8.1.3. Bi-Ventricular Assist Device
  • 8.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 8.2.1. Pulsatile Flow
    • 8.2.2. Continuous Flow
  • 8.3. Market Analysis, Insights and Forecast - By Application
    • 8.3.1. Bridge to Transplant (BTT)
    • 8.3.2. Bridge to Candidacy (BTC)
    • 8.3.3. Destination Therapy (DT)
    • 8.3.4. Bridge to Recovery (BTR)
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals & ASCs
    • 8.4.2. Specialty Clinics & Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 8.5.1. China
      • 8.5.1.1. By Product
    • 8.5.2. Japan
      • 8.5.2.1. By Product
    • 8.5.3. India
      • 8.5.3.1. By Product
    • 8.5.4. Australia
      • 8.5.4.1. By Product
    • 8.5.5. Southeast Asia
      • 8.5.5.1. By Product
    • 8.5.6. Rest of Asia Pacific
      • 8.5.6.1. By Product

9. Latin America Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Left Ventricular Assist Device
    • 9.1.2. Right Ventricular Assist Device
    • 9.1.3. Bi-Ventricular Assist Device
  • 9.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 9.2.1. Pulsatile Flow
    • 9.2.2. Continuous Flow
  • 9.3. Market Analysis, Insights and Forecast - By Application
    • 9.3.1. Bridge to Transplant (BTT)
    • 9.3.2. Bridge to Candidacy (BTC)
    • 9.3.3. Destination Therapy (DT)
    • 9.3.4. Bridge to Recovery (BTR)
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals & ASCs
    • 9.4.2. Specialty Clinics & Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 9.5.1. Brazil
      • 9.5.1.1. By Product
    • 9.5.2. Mexico
      • 9.5.2.1. By Product
    • 9.5.3. Rest of the LATAM
      • 9.5.3.1. By Product

10. Middle East & Africa Ventricular Assist Device Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Left Ventricular Assist Device
    • 10.1.2. Right Ventricular Assist Device
    • 10.1.3. Bi-Ventricular Assist Device
  • 10.2. Market Analysis, Insights and Forecast - By Type of Flow
    • 10.2.1. Pulsatile Flow
    • 10.2.2. Continuous Flow
  • 10.3. Market Analysis, Insights and Forecast - By Application
    • 10.3.1. Bridge to Transplant (BTT)
    • 10.3.2. Bridge to Candidacy (BTC)
    • 10.3.3. Destination Therapy (DT)
    • 10.3.4. Bridge to Recovery (BTR)
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals & ASCs
    • 10.4.2. Specialty Clinics & Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-Region
    • 10.5.1. GCC
      • 10.5.1.1. By Product
    • 10.5.2. South Africa
      • 10.5.2.1. By Product
    • 10.5.3. Rest of Middle East & Africa
      • 10.5.3.1. By Product

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Berlin HeartOverview
      • 11.2.1.1. Products & Services
      • 11.2.1.2. SWOT Analysis
      • 11.2.1.3. Recent Developments
      • 11.2.1.4. Strategies
      • 11.2.1.5. Financials (Based on Availability)
    • 11.2.2. ABIOMED
      • 11.2.2.1. Products & Services
      • 11.2.2.2. SWOT Analysis
      • 11.2.2.3. Recent Developments
      • 11.2.2.4. Strategies
      • 11.2.2.5. Financials (Based on Availability)
    • 11.2.3. Abbott
      • 11.2.3.1. Products & Services
      • 11.2.3.2. SWOT Analysis
      • 11.2.3.3. Recent Developments
      • 11.2.3.4. Strategies
      • 11.2.3.5. Financials (Based on Availability)
    • 11.2.4. Jarvik Heart, Inc.
      • 11.2.4.1. Products & Services
      • 11.2.4.2. SWOT Analysis
      • 11.2.4.3. Recent Developments
      • 11.2.4.4. Strategies
      • 11.2.4.5. Financials (Based on Availability)

List of Tables

  • Table 1: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 2: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, By Type of Flow, 2021-2034
  • Table 3: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 4: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 5: Global Ventricular Assist Device Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 7: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 8: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 9: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 10: North America Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: U.S. Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 12: Canada Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 13: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 14: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 15: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 16: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 17: Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 18: Germany Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 19: U.K. Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 20: France Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 21: Italy Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 22: Spain Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 23: Scandinavia Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 24: Rest of Europe Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 25: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 26: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 27: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 28: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 29: Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 30: Japan Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 31: India Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 32: China Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 33: Australia Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 34: Southeast Asia Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 35: Rest of Asia Pacific Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 36: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 37: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 38: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 39: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 40: Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 41: Brazil Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 42: Mexico Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 43: Rest of Latin America Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 44: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 45: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Type of Flow, 2021-2034
  • Table 46: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Application, 2021-2034
  • Table 47: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 48: Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 49: GCC Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 50: South Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034
  • Table 51: Rest of Middle East & Africa Ventricular Assist Device Market Revenue (USD billion) Forecast, by Product, 2021-2034

List of Figures

  • Figure 1: Global Ventricular Assist Device Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Ventricular Assist Device Market Value Share (%), by Product, 2025 & 2034
  • Figure 3: Global Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025 & 2034
  • Figure 4: Global Ventricular Assist Device Market Value Share (%), by Application, 2025 & 2034
  • Figure 5: Global Ventricular Assist Device Market Value Share (%), by End-user, 2025 & 2034
  • Figure 6: Global Ventricular Assist Device Market Value (USD billion), by Region, 2025 & 2034
  • Figure 7: North America Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 8: North America Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 9: North America Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 10: North America Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 11: North America Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 12: North America Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 13: North America Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 14: North America Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 15: North America Ventricular Assist Device Market Value (USD billion), By Country, 2025 & 2034
  • Figure 16: North America Ventricular Assist Device Market Value Share (%), By Country, 2025
  • Figure 17: Europe Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 18: Europe Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 19: Europe Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 20: Europe Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 21: Europe Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 22: Europe Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 23: Europe Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 24: Europe Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 25: Europe Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 26: Europe Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 27: Asia Pacific Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 28: Asia Pacific Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 29: Asia Pacific Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 30: Asia Pacific Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 31: Asia Pacific Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 32: Asia Pacific Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 33: Asia Pacific Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 34: Asia Pacific Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 35: Asia Pacific Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 36: Asia Pacific Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 37: Latin America Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 38: Latin America Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 39: Latin America Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 40: Latin America Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 41: Latin America Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 42: Latin America Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 43: Latin America Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 44: Latin America Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 45: Latin America Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 46: Latin America Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 47: Middle East & Africa Ventricular Assist Device Market Value (USD billion), by Product, 2025 & 2034
  • Figure 48: Middle East & Africa Ventricular Assist Device Market Value Share (%), by Product, 2025
  • Figure 49: Middle East & Africa Ventricular Assist Device Market Value (USD billion), By Type of Flow, 2025 & 2034
  • Figure 50: Middle East & Africa Ventricular Assist Device Market Value Share (%), By Type of Flow, 2025
  • Figure 51: Middle East & Africa Ventricular Assist Device Market Value (USD billion), by Application, 2025 & 2034
  • Figure 52: Middle East & Africa Ventricular Assist Device Market Value Share (%), by Application, 2025
  • Figure 53: Middle East & Africa Ventricular Assist Device Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 54: Middle East & Africa Ventricular Assist Device Market Value Share (%), by End-user, 2025
  • Figure 55: Middle East & Africa Ventricular Assist Device Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 56: Middle East & Africa Ventricular Assist Device Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 57: Global Ventricular Assist Device Market Share (%), By Company, 2025